RediCare

RediCare ControlDTx Wins First Prize at the Centre for Population Health Conference 2024

We’re proud to share that our poster presentation, "Demonstrating Impact at Scale and Reducing Inequalities," was awarded first prize at the recent Centre for Population Health Conference in Bradford. 

The conference brought together professionals from across health and care to discuss practical ways to improve population health and tackle health inequalities. The conference emphasised the importance of prevention and collaboration in achieving a healthier, more equitable society.  

Our Chief Medical Officer, Dr. Donal Collins, attended the event to showcase RediCare’s work. His presentation highlighted how our evidence-based programme provides accessible, scalable solutions that empower individuals to improve their health and reduce reliance on already stretched healthcare services. 

About the Conference 

The Centre for Population Health Conference focuses on helping health and care staff across all roles and disciplines, make meaningful progress in improving population health and reducing health disparities. It is clear the challenge lies in translating ambition and existing evidence, into effective action. 

RediCare are Reducing Inequalities 

At RediCare, we support primary care by addressing the root causes of chronic conditions such Type 2 Diabetes, Non-Diabetic Hyperglycaemia, Overweight Conditions, NAFLD and PCOS. Our digital therapeutics programme is designed to: 

  • Provide practical, sustainable solutions to improve health outcomes. 

  • Reduce health inequalities by making prevention accessible to more people. 

  • Support individuals to take control of their health through evidence-based education and guidance. 

Each month, new cohorts of patients join our programme, starting their journey toward effective chronic disease prevention and management. Our approach ensures sustainable, long-term health improvements with proven results. 

 

 

Recognition for Driving Impact 

Winning first prize at the Population Health Conference highlights the significant, measurable impact RediCare is delivering on a large scale. It reinforces the value of prevention-focused, evidence-based approaches in tackling the complex health challenges faced by individuals and communities. The link to view our winning poster can be found here

We sincerely thank the Centre for Population Health for acknowledging our work and providing a platform to share impactful insights and innovations driving meaningful change. You can read more about the conference here. 

If you’d like to learn more about how RediCare can support your health and care goals, please  contact us at info@controldtx.com or you can book a discovery call via the following link here. 

 

About RediCare

RediCare is a digital therapeutics firm. With our core product RediCare ControlDTx patients are transforming their health across the spectrum of metabolic health. They are experiencing clinically significant reductions in Weight, HbA1c, Blood Pressure and improved Lipid profiles and PCOS remission. Many Type 2 Diabetic patients have reduced and eliminated their diabetes medications.

RediCare ControlDTx is creating a new normal in prescription digital therapeutics for treating cardiometabolic diseases. We envision a new way to treat diseases like Type 2 diabetes and heart disease by targeting the root cause, not just the effects, using prescription digital therapeutics to deliver personalized clinically validated lifestyle therapy.

RediCare partners with primary care practices in the UK and Ireland and serves over 140 corporate clients with chronic disease screening and management services.